Figure 1.
Clinical endpoints after 12 weeks of therapy with upadacitinib. The primary endpoint was clinical remission (Harvey-Bradshaw index ≤ 3).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.